Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

EJHaem

Showing results (1-10 of 1,352) with videos related to

Pageof 136
Sort By:
Ejhaem|October 19, 2020
Pevonedistat, a NEDD8-Activating Enzyme Inhibitor, Induces Apoptosis and Augments Efficacy of Chemotherapy and Small Molecule Inhibitors in Pre-clinical Models of Diffuse Large B-cell LymphomaPallawi Torka, Cory Mavis, Shalin Kothari, et al.
Ejhaem|July 6, 2021
Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccineMona Al-Ahmad, Mona Al-Rasheed, Neveen Abo Bakr Shalaby
Ejhaem|July 6, 2021
In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective studyMohammed Al-Jarallah, Rajesh Rajan, Ahmad Al Saber, et al.
Ejhaem|July 6, 2021
Models of care for chronic myeloid leukemia patients during the COVID-19 pandemic in the United Kingdom: Changes in patient attitudes to remote consultations and future implicationsNicholas Duncan, Nigel Deekes, David FitzGerald, et al.
Ejhaem|December 5, 2022
Acute haemothorax secondary to ibrutinib: A case reportJessica Sue Yi Wong, Shalal Sadullah
Ejhaem|December 5, 2022
'Harlequin cells' in lymphocyte-variant hypereosinophiliaAmirali Vahedi, Tahereh Madani, Behrooz Gharib, et al.
Ejhaem|December 5, 2022
Understanding real-world treatment patterns and clinical outcomes in AL amyloidosis patients diagnosed in Canada: A population-based cohort studyVictor H Jimenez-Zepeda, Donna Reece, Rodrigo Rigo, et al.
Ejhaem|December 5, 2022
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatmentMuhamed Baljevic, Cristina Gasparetto, Gary J Schiller, et al.
Ejhaem|December 5, 2022
Bortezomib-based therapy is effective and well tolerated in frontline and multiply pre-treated Waldenström macroglobulinaemia including BTKi failures: A real-world analysisJahanzaib Khwaja, Encarl Uppal, Robert Baker, et al.
Ejhaem|December 5, 2022
Aberrant expression of cytokeratin in plasma cell neoplasms: A pitfall for diagnostic errorsMichelle Huang, Ali Sakhdari
Pageof 136

Showing results (1-10 of 1,352) with videos related to

Sort By:
Pageof 136
Ejhaem|October 19, 2020
Pevonedistat, a NEDD8-Activating Enzyme Inhibitor, Induces Apoptosis and Augments Efficacy of Chemotherapy and Small Molecule Inhibitors in Pre-clinical Models of Diffuse Large B-cell LymphomaPallawi Torka, Cory Mavis, Shalin Kothari, et al.
Ejhaem|July 6, 2021
Acquired thrombotic thrombocytopenic purpura with possible association with AstraZeneca-Oxford COVID-19 vaccineMona Al-Ahmad, Mona Al-Rasheed, Neveen Abo Bakr Shalaby
Ejhaem|July 6, 2021
In-hospital mortality in SARS-CoV-2 stratified by hemoglobin levels: A retrospective studyMohammed Al-Jarallah, Rajesh Rajan, Ahmad Al Saber, et al.
Ejhaem|July 6, 2021
Models of care for chronic myeloid leukemia patients during the COVID-19 pandemic in the United Kingdom: Changes in patient attitudes to remote consultations and future implicationsNicholas Duncan, Nigel Deekes, David FitzGerald, et al.
Ejhaem|December 5, 2022
Acute haemothorax secondary to ibrutinib: A case reportJessica Sue Yi Wong, Shalal Sadullah
Ejhaem|December 5, 2022
'Harlequin cells' in lymphocyte-variant hypereosinophiliaAmirali Vahedi, Tahereh Madani, Behrooz Gharib, et al.
Ejhaem|December 5, 2022
Understanding real-world treatment patterns and clinical outcomes in AL amyloidosis patients diagnosed in Canada: A population-based cohort studyVictor H Jimenez-Zepeda, Donna Reece, Rodrigo Rigo, et al.
Ejhaem|December 5, 2022
Selinexor-based regimens in patients with multiple myeloma after prior anti-B-cell maturation antigen treatmentMuhamed Baljevic, Cristina Gasparetto, Gary J Schiller, et al.
Ejhaem|December 5, 2022
Bortezomib-based therapy is effective and well tolerated in frontline and multiply pre-treated Waldenström macroglobulinaemia including BTKi failures: A real-world analysisJahanzaib Khwaja, Encarl Uppal, Robert Baker, et al.
Ejhaem|December 5, 2022
Aberrant expression of cytokeratin in plasma cell neoplasms: A pitfall for diagnostic errorsMichelle Huang, Ali Sakhdari
Pageof 136